EICHOR
● Active Not Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer · KRAS G12C Lung Cancer · Sponsor: Hoffmann-La Roche
About this study
The purpose of this study is to assess the safety and efficacy of divarasib compared to locally approved KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung cancer (NSCLC).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (151)
| Banner Health MD Anderson AZ | Gilbert, Arizona, United States | — |
| Los Angeles Cancer Network | Los Angeles, California, United States | — |
| UCLA Hematology / Oncology Clinic | Los Angeles, California, United States | — |
| University of California, San Francisco | San Francisco, California, United States | — |
| Yale Cancer Center | New Haven, Connecticut, United States | — |
| University of Miami | Miami, Florida, United States | — |
| Florida Cancer Specialists - North;725 6th Ave South (St. Petersburg) | St. Petersburg, Florida, United States | — |
| University of Chicago Medical Center | Chicago, Illinois, United States | — |
| New England Cancer Specialists | Westbrook, Maine, United States | — |
| Dana Farber Cancer Institute | Boston, Massachusetts, United States | — |
| University of Michigan | Ann Arbor, Michigan, United States | — |
| Cancer and Hematology Centers of Western Michigan | Grand Rapids, Michigan, United States | — |
+ 139 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06497556